Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CSTONE-PHARMACEUTICALS-57946082/news/CStone-Pharmaceuticals-Announces-Two-Key-Phase-3-Registrational-Clinical-Trials-of-Sugemalimab-Compl-37574306/?utm_source=whatsapp&utm_medium=social&utm_campaign=share